Professor Miles Houslay

Research Professor

Strathclyde Institute of Pharmacy and Biomedical Sciences

Contact

Personal statement

Miles Houslay is internationally recognised for his work in cell signalling. He is particularly interested in understanding how the functioning of cyclic nucleotide signaling networks are regulated by spatial constraints and cross-talk. His research focus concerns the functional significance of targeted cAMP degradation by PDE4 phosphodiesterase isoforms and developing novel therapeutics for diseases such as COPD, cancer and schizophrenia. He has published over 440 research papers, holds a number of patents and has acted either as a consultant or served on scientific advisory boards of various companies in Asia, Europe, Japan, UK and USA. He has a research publication H-index of 77 (January 2013).

Back to staff profile

Publications

Creating a potential diagnostic for prostate cancer risk stratification (InformMDx™) by translating novel scientific discoveries concerning cAMP degrading phosphodiesterase-4D7 (PDE4D7)
Henderson Dave JP, Houslay Miles D, Bangma Chris H, Hoffmann Ralf
Clinical Science Vol 133, pp. 269-286 (2019)
https://doi.org/10.1042/CS20180519
The role of ventral striatal cAMP signaling in stress-induced behaviors
Plattner Florian, Hayashi Kanehiro, Hernández Adan, Benavides David R, Tassin Tara C, Tan Chunfeng, Day Jonathan, Fina Maggy W, Yuen Eunice Y, Yan Zhen, Goldberg Matthew S, Nairn Angus C, Greengard Paul, Nestler Eric J, Taussig Ronald, Nishi Akinori, Houslay Miles D, Bibb James A
Nature Neuroscience Vol 18, pp. 1094-11100 (2015)
https://doi.org/10.1038/nn.4066
Nuclear pore complex remodeling by p75(NTR) cleavage controls TGF-β signaling and astrocyte functions
Schachtrup Christian, Ryu Jae Kyu, Mammadzada Könül, Khan Abdullah S, Carlton Peter M, Perez Alex, Christian Frank, Le Moan Natacha, Vagena Eirini, Baeza-Raja Bernat, Rafalski Victoria, Chan Justin P, Nitschke Roland, Houslay Miles D, Ellisman Mark H, Wyss-Coray Tony, Palop Jorge J, Akassoglou Katerina
Nature Neuroscience Vol 18, pp. 1077-1080 (2015)
https://doi.org/10.1038/nn.4054
Hypertension linked to PDE3A activation
Houslay Miles
Nature Genetics Vol 47, pp. 562-563 (2015)
https://doi.org/10.1038/ng.3316
Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains
Bolger Graeme B, Dunlop Allan J, Meng Dong, Day Jon P, Klussmann Enno, Baillie George S, Adams David R, Houslay Miles D
Cellular Signalling Vol 27, pp. 756-769 (2015)
https://doi.org/10.1016/j.cellsig.2014.12.009
The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells
Henderson D J P, Byrne A, Dulla K, Jenster G, Hoffmann R, Baillie G S, Houslay M D
British Journal of Cancer Vol 110, pp. 1278-1287 (2014)
https://doi.org/10.1038/bjc.2014.22

More publications

Back to staff profile

Projects

Identifying selective cAMP phosphodiesterase inhibitors for chronic obstructive pulmonary disease
Houslay, Miles (Principal Investigator)
01-Jan-2012 - 30-Jan-2015
Novel Therapies For COPD - PoC
Houslay, Miles (Principal Investigator) Pyne, Nigel (Co-investigator)
21-Jan-2012 - 08-Jan-2014

More projects

Back to staff profile

Contact

Professor Miles Houslay
Research Professor
Strathclyde Institute of Pharmacy and Biomedical Sciences

Email: miles.houslay@strath.ac.uk
Tel: 548 2125